- Home
- MLTX vs SGHC Comparison
MLTX vs SGHC Comparison
Compare MLTX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | SGHC |
|---|---|---|
| Founded | 2021 | 2020 |
| Country | Switzerland | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 7.1B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MLTX | SGHC |
|---|---|---|
| Price | $12.47 | $12.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $27.50 | $17.33 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.09 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | ★ N/A | $20.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $8.46 |
| 52 Week High | $62.75 | $15.86 |
Technical Indicators
Market Signals| Indicator | MLTX | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 24.49 | 33.95 |
| Support Level | $11.06 | $12.46 |
| Resistance Level | $19.24 | $13.02 |
| Average True Range (ATR) | 0.66 | 0.41 |
| MACD | -0.12 | -0.11 |
| Stochastic Oscillator | 12.40 | 10.95 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.